CompletedNot Applicable

Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure

Canada324 participantsStarted 2015-04-01

Plain-language summary

A retrospective cohort study of all patients treated for type II (hypercapnic) respiratory failure with either High-Flow Oxygen Therapy or Non-Invasive Ventilation in a general adult hospital.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients treated with respiratory failure not responding to conventional supplemental oxygen therapy * Blood venous gas showing partial pressure of carbon dioxide\>50 mmHg before beginning therapy with either NIV or HFNC Exclusion Criteria: * Lack of records of the primary outcome * End-of-life care * Lack of gas before the beginning of NIV or HFNC

What they're measuring

Failure of initial treatment (combined outcome)

Timeframe: 48 hours post intervention

Death at 48h

Timeframe: 48 hours post intervention

Trial details

NCT IDNCT03443479

SponsorHôpital de Verdun

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-07-01

View on ClinicalTrials.gov More Respiratory Failure trials